Turning the power of nuclear technology into a medical force
Not your grandparents’ nuclear medicine
About Advanced Accelerator Applications
1 of the 4
platforms of the Novartis Bold4Cure strategy
Founded in 2002, AAA has a strong legacy as a pioneer in nuclear medicine.
We believe targeted radioligand therapy has the potential to be broadly used in many different tumor types.